Alpha Tau Medical Ltd. (NASDAQ: DRTS) shares climbed 25.26% in after-hours trading to $5.30, after the company announced the first patient treatment in its pilot study for recurrent glioblastoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback